88Q fundamentals
An in-depth look to 4BASEBIO PLC EO 1 operating, investing, and financing activities
88Q free cash flow for H2 24 is -7.34 M EUR. For 2024, 88Q free cash flow was -13.84 M EUR and operating cash flow was -13 M EUR.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM